Publications
Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...
With the ink dry about a month on the recent FDA approval of Philips Intellisite Pathology Solution (PIPS) for primary diagnosis, I came across this headline and others like it last week. Well known, respected pathologists and pathology...
Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary surgical pathology diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA...
“Academic” Tweeting – Is it “Academic”...
Dr. Bruce Friedman over at Lab Soft News has an interesting post today on "The "Why" and "How" of Academic Tweeting". Many of you know that Bruce is widely considered the grandfather of pathology informatics, coining the term decades ago,...
Corista Announces Platform Integration and Collaboration with Elsev...
- Anatomic Pathology
- Business
- Clinical Laboratories
- Clinical Pathology
- Conferences
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- Histology
- Informatics
- Laboratory Informatics
- Laboratory Management & Operations
- Medical Research
- Pathology News
- Publications
- Vendor products
- Web/Tech
- Whole slide
DP3 Digital Pathology Platform now offers Instant Access to Elsevier’s ExpertPathTM image library Concord, MA -- Corista, a leader in integrated pathology solutions, today announced its collaboration with Elsevier, a world-leading provider...
Courtesy of Clinical OMICs - Molecular Diagnostics in Personalized Medicine Johns Hopkins researchers have published new data that suggests epigenetic changes controlling how DNA operates, provides survival advantages to a subset of...






























